Avenue Therapeutics, Inc. - ATXI

About Gravity Analytica
Recent News
- 12.05.2025 - DEF 14A - Definitive proxy statements
- 11.18.2025 - 8-K - Current report
- 11.13.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
- 11.12.2025 - 8-K - Current report
- 08.14.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
- 07.18.2025 - 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
- 05.15.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
- 04.30.2025 - 8-K - Current report
- 04.02.2025 - SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership
- 04.02.2025 - 4 - Statement of changes in beneficial ownership of securities
Recent Filings
- 11.18.2025 - 8-K Current report
- 11.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 11.12.2025 - EX-99.1 EX-99.1
- 11.12.2025 - 8-K Current report
- 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 07.18.2025 - 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
- 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 04.30.2025 - 8-K Current report
- 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.02.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership